Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.
Conteduca V, Crabb SJ, Jones RJ, Caffo O, Elliott T, Scarpi E, Fabbri P, Derosa L, Massari F, Numico G, Zarif S, Hanna C, Maines F, Joyce H, Lolli C, De Giorgi U.
Conteduca V, et al. Among authors: zarif s.
PLoS One. 2016 Jul 19;11(7):e0158952. doi: 10.1371/journal.pone.0158952. eCollection 2016.
PLoS One. 2016.
PMID: 27434372
Free PMC article.